Cartesian Therapeutics Inc
RNAC
NASDAQ
Biotechnology
$8.84
USD
+0.12 (+1.38%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $267.91M
Volume 86.4K
Price Target
$38.00 – $44.00
USD
The 3 analysts offering 1-year price forecasts have a max estimate of $44.00 and a min estimate of $38.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$40.67
+$10.4 vs prior
Implied Upside
+360.1%
+117.9% vs prior
Analyst Covering
3
-1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
43%
A mix of recent and older ratings shape this consensus
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$0.6700 Gap
Median $40.00 vs avg $40.67 - a few bullish outliers are pulling the average up
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
3 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
3 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Martin Fan | Wedbush | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Julian Harrison | BTIG | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Gil Blum | Needham | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
